Meylan, France

Dominique Mariais

This inventor holds 1 USPTO granted patent. Top assignee: Merck Patent Gesellschaft MIT Beschrankter Haftung. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dominique Mariais. Retrieved from https://idiyas.com/inventor/dominique-mariais

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Dominique Mariais

Introduction

Dominique Mariais is a notable inventor based in Meulan, France. He has made significant contributions to the field of medicine, particularly in the treatment of diabetes. His innovative work has led to the development of a unique patent that addresses a critical health issue.

Latest Patents

Mariais holds a patent for "Kynurenine 3-hydroxylase inhibitors for the treatment of diabetes." This invention relates to the use of at least one compound with inhibitory activity on kynurenine 3-hydroxylase for the preparation of a medicament aimed at the prevention and/or treatment of diabetes. This patent highlights his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Dominique Mariais is associated with Merck Patent Gesellschaft mit beschränkter Haftung, a leading company in the pharmaceutical industry. His work at Merck has allowed him to collaborate with other talented professionals and contribute to groundbreaking research in diabetes treatment.

Collaborations

Mariais has worked alongside esteemed colleagues such as Valerie Autier and Annick Arbellot De Vacqueur. These collaborations have fostered an environment of innovation and have been instrumental in the development of his patent.

Conclusion

Dominique Mariais is a distinguished inventor whose work in diabetes treatment exemplifies the impact of innovative thinking in medicine. His patent for kynurenine 3-hydroxylase inhibitors represents a significant advancement in the field, showcasing his dedication to improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…